Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population studyAntonietta Romano, A. Albertí, Paolo Angeli et al.|Journal of Hepatology|2018Cited by 166
Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort studyDaniele Roberto Giacobbe, Giovanna Travi, Claudia Bartalucci et al.|JAC-Antimicrobial Resistance|2025Cited by 4
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective studyDaniele Roberto Giacobbe, Małgorzata Mikulska, Greta Cattardico et al.|Critical Care|2025Cited by 2
THU-166-Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from ItalyL. Pasulo, Antonio Albanese, Caterina Uberti‐Foppa et al.|Journal of Hepatology|2019Cited by 1
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from ItalyL. Pasulo, Giuliana Cologni, M. Gambato et al.|Digestive and Liver Disease|2019Cited by 1